Comparing cefazolin/metronidazole, piperacillin‐tazobactam, or cefoxitin as surgical antibiotic prophylaxis in patients undergoing pancreaticoduodenectomy: A retrospective cohort study

Documenti analoghi

• Understanding futility in pancreaticoduodenectomy: Insights from a national cohort
  di: Clayton T. Marcinak, et al.
  Pubblicazione: (2024)
• Neoadjuvant chemotherapy is associated with improved disease‐free survival in pancreatic cancer patients undergoing pancreaticoduodenectomy with vascular resection
  di: Dustin L. Dillon, et al.
  Pubblicazione: (2024)
• Celiac artery stenosis and its impact on postoperative outcomes following pancreaticoduodenectomy: An institutional analysis
  di: Shamsher A. Pasha, et al.
  Pubblicazione: (2024)
• The benefit of adjuvant chemotherapy following pancreaticoduodenectomy for pancreatic adenocarcinoma depends on response to neoadjuvant therapy
  di: Elizabeth L. Carpenter, et al.
  Pubblicazione: (2024)
• Impact of the pandemic on surgical oncology in Piedmont, Italy: A retrospective observational study
  di: Giuseppina Lo Moro, et al.
  Pubblicazione: (2024)